Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.
about
Emerging treatments in Castleman disease - a critical appraisal of siltuximabInterleukin-6 blockade in ocular inflammatory diseasesGenetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.IL-6 in inflammation, immunity, and diseaseHyper-inflammation and skin destruction mediated by rosiglitazone activation of macrophages in IL-6 deficiency.Anti-inflammatory effects of adenosine N1-oxideLow baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients.Mitochondrial Ca²⁺ and membrane potential, an alternative pathway for Interleukin 6 to regulate CD4 cell effector functionDiscovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo.Excessive Pro-Inflammatory Serum Cytokine Concentrations in Virulent Canine Babesiosis.Inflammatory Kinetics and Efficacy of Anti-inflammatory Treatments on Human Nucleus Pulposus Cells.Analysis of a Functional IL-6 Gene Polymorphism in HLAB27 Associated and Intermediate Uveitis Gives New Insight in Disease Pathogenesis and Commonality with Other Autoimmune DiseasesImmunoinflammatory diseases of the central nervous system - the tale of two cytokines.Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis.Antiretroviral Therapy Normalizes Autoantibody Profile of HIV Patients by Decreasing CD33⁺CD11b⁺HLA-DR⁺ Cells: A Cross-Sectional Study.MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1.Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy.Serum interleukin-6 expression level and its clinical significance in patients with dermatomyositisEmerging roles of immunostimulatory oral bacteria in periodontitis development.Meprin metalloproteases inactivate interleukin 6.Splenic stromal cells from aged mice produce higher levels of IL-6 compared to young mice.In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome.Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?Inhibition of the interleukin-6 signaling pathway: a strategy to induce immune tolerance.Hidradenitis suppurativa: the role of immune dysregulation.Regulatory tone and mucosal immunity in asthmaChemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor.The impact of biological therapy on regulatory T cells in rheumatoid arthritis.Achieving incompatible transplantation through desensitization: current perspectives and future directions.A new alternative therapy in dermatology: tocilizumab.MAP Kinase Cascades in Antigen Receptor Signaling and Physiology.The effect of chronic ammonia exposure on acute-phase proteins, immunoglobulin, and cytokines in laying hens.Bidirectional role of IL-6 signal in pathogenesis of lung fibrosis.N-acetylcysteine and azithromycin affect the innate immune response in cystic fibrosis bronchial epithelial cells in vitro.Establishment of an in vitro three-dimensional model for cartilage damage in rheumatoid arthritis.Herpesvirus microRNAs for use in gene therapy immune-evasion strategies.Comparisons of the outcomes between early and late tocilizumab treatment in systemic juvenile idiopathic arthritis.Association study of interleukin-1 family and interleukin-6 gene single nucleotide polymorphisms in recurrent aphthous stomatitis.Xuebijing injection improves the respiratory function in rabbits with oleic acid-induced acute lung injury by inhibiting IL-6 expression and promoting IL-10 expression at the protein and mRNA levels.Special issue on interleukin-6 (IL-6).
P2860
Q26766554-B78C3521-C634-4681-B8E0-102AC42545C2Q27011357-48BE4BAB-26DE-4843-A84A-ED658D635F7FQ33714950-781E68F0-F539-4BBD-ADB5-AB5A110F63C4Q34248105-8A3BF10D-BF4C-4F98-AD94-0B518BD13D1EQ34926832-6A00A007-B5ED-4167-B584-8EBF63EC90EFQ35021016-627D096A-3881-437E-A802-8A19C555B594Q35438412-5BC30187-0464-495F-B2D0-A95356C69E99Q35662424-325BD6FB-C8C9-41B2-BE64-3D17C5398F9EQ35837523-F9A4104E-0EBD-4342-9C38-E64F5F2A686DQ35949034-27DAD56A-3481-49C9-BFC5-331FA7AD1250Q36052980-B5C905CE-435F-4CDD-887F-5B2FA889DAADQ36310417-32DC7A60-B7ED-423F-8937-B59D29146E04Q36547012-1C12B47B-FDC0-4E08-8529-B92F08DF78F2Q36682022-E1F42958-6790-4CF2-93B6-A115A653DDB3Q36822345-42A0D43D-94B7-49DE-86BF-A25DD50D3BA4Q36870550-A486E293-B47F-48DC-81AC-746520AC75F5Q36975028-80919F19-4ACB-4094-B930-6D7BD479CD03Q37180624-CCEFBDA1-7C6F-433C-80E2-8E52700285D8Q37619440-F95ED48B-F36B-4C51-88CA-3E7C4D96FB40Q37635798-2EAF85CB-B147-4D08-A65D-26DDAAC915A1Q37651109-0C3EC422-466E-4589-8AD1-C6171C9C5B5AQ37689751-D4610783-EE0E-4E0D-9B02-1304CFD695A3Q38189135-EA5BD4B0-057F-49A7-BFE7-25404EE029BFQ38197519-DBE95529-C742-4559-B502-FD7B564B5243Q38222887-7EAD8286-E941-42BF-B530-B58B56E7B706Q38224322-A6CC4DA4-4844-462F-86BF-7ABF1C7303B7Q38309810-47B25304-8A81-4579-A4AC-187C4205AF71Q38350483-0F670E04-5697-4D2B-8601-A23699E46267Q38445336-BC0F4ED5-A1E5-44E3-B17C-3B03FA996DF2Q38507301-81EA3F04-D18B-4FB6-A4CE-C3E5D3DACCBFQ38567096-D941A351-42D5-41FC-A3FA-BC26287B600BQ38734693-99C817B2-E7ED-46C6-8772-103A572BFF9CQ38842453-8576D320-3C07-4ECA-8BB1-19A8C636811EQ38972117-75350FD1-260D-4029-8076-8EB6EF86D14DQ39024735-0E60581E-7BA5-49DF-8160-DAE4858B5D6BQ39293464-6263C172-E499-4F19-AFC9-6E522F0D356CQ40502733-A07C2849-5CD4-44A7-9E8D-5E566B6708FAQ41346142-3587C5E3-4356-4243-BCF9-E1E7A14D2F60Q41942967-156A2FB5-45AA-4000-9CEF-6AD42669EA3AQ42361706-1D63E9C6-2964-4AA1-AE21-CC71AEF30C27
P2860
Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.
@en
type
label
Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.
@en
prefLabel
Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.
@en
P2860
P921
P356
P1476
Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.
@en
P2093
Tadamitsu Kishimoto
Toshio Tanaka
P2860
P304
P356
10.7150/IJBS.4666
P407
P577
2012-10-24T00:00:00Z